Pharmaceutical Executive-08-01-2015

The need for biopharma executives to combine a "culture of quality" with value-added processes and improvements in the area drug manufacturing is critical. Here are steps and strategies than can help.

Commercial success for pharma brands now demands proactive strategies and interventions

Experts from industry and academia probe the changing role of the pharmacoepidemiology function as it grapples with the challenges of big data analytics, tightening drug safety requirements, growing post-approval study burdens, and payer expectations around the application of real-world evidence.

The case of Amgen v. Sandoz signals that preliminary injunctions will play major role in future patent disputes

FDA reform may get tangled up in user fee negotiations, budget debate

The volatility of nation's crisis could pose greater challenges down the line

Despite rising healthcare costs, Algeria, the second-largest pharmaceutical market in Africa, remains optimistic about its pharma sector, which is riding the momentum of recent healthcare reforms. Manufacturing challenges and a growing prevalence of chronic disease, however, offer pause to the bright scenario.